Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 488 (CSE: $CURA.C) (OTCQX: $CURLF) (OTC: $MJNA) (CSE: $DIXI_U.C), (OTCQX: $DXBRF)
Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 29, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/102920-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10291CURA-CURLF-MJNA-DIXI-DXBRF.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today’s podcast we look at a few public and private company announcements.
Dixie Brands Inc. (CSE: DIXI.U), (OTCQX: DXBRF) and BR Brands, LLC announced that the previously disclosed reverse takeover transaction of Dixie by BR Brands will be completed on Saturday, October 31, 2020. The combined company has been renamed BellRock Brands Inc. and Dixie's stock symbol on the Canadian Securities Exchange will be changed to "BRCK." Dixie anticipates that trading of its shares will recommence on or about November 4, 2020.
"We are pleased to announce the upcoming closing of the business combination of BR Brands and Dixie. This transformative transaction was the result of a long-term strategic and value focused approach to building a dominant house of brands within the cannabis sector," said Andrew Schweibold, former Chairman of BR Brands and new Chairman of BellRock.
"BellRock unites two of the most established brands in cannabis to create an IP and brand-focused multi-state operator, unique in its strategy and scale. Under BellRock management, the platform is poised for exponential growth, through both M&A and organic R&D, and is purposely built to cater to all of the industry's fastest growing segments."
BellRock's portfolio consists of two iconic cannabis brands with deep history, Mary's Brands ("Mary's") and Dixie, as well as two growing, California-based brands, Rebel Coast and Défoncé.
Mary's, founded in 2013, is the innovator of cannabis and hemp-infused products for adult use, medical, skincare, wellness and pet markets, and the company's robust library of intellectual property includes a U.S. patent for its acclaimed transdermal technology. Since 2010, Dixie has created a wide array of award-winning beverages, gummies, mints, and taffies as well as two well recognized CBD supplement brands; Aceso Wellness and Therabis. Together, the BellRock brands offer one of the largest spectrums of high-quality consumer packaged goods in the cannabis industry. With 11 brands and over 200 SKUs, BellRock reaches nearly every key consumer group and addresses the needs of a diverse cannabis consumer base. The BellRock manufacturing and distribution footprint continues to expand and currently spans nine states, and the company owns or manages production facilities in its largest markets.
"The joining of BR Brands and Dixie is unique in that together, BellRock possesses one of the industry's broadest branded product portfolios catering to the growing and ever-evolving cannabis consumer. Our portfolio is one of the most diversified in the industry and is based on our relentless pursuit of enhancing the consumer experience," said Chuck Smith, Chief Executive Officer of BellRock Brands.
BellRock brings together a seasoned leadership team of CPG and cannabis executives with unrivaled financial, capital markets and consumer brands expertise. The Board of Directors of BellRock will be comprised of three nominees of BR Brands and two nominees of Dixie. Andrew Schweibold, previously Chairman of BR Brands, will serve as Chairman of the Board. Chuck Smith, former President and Chief Executive Officer of Dixie, assumes the role of BellRock CEO and joins the BellRock Board. Sat Joshi, former Chief Executive Officer of BR Brands, steps down from the executive position and joins the Board. The Board of Directors also includes Jonathan Rosenthal, Co-Founder and Managing Partner at Rose Capital, and Brian Graham, a seasoned CPG industry executive.
BellRock began executing its integration strategy earlier in the year, already yielding operational synergies and unlocking opportunities to grow revenue and cash flow. The company has already unified its sales team in Colorado and efforts to consolidate manufacturing and sales in other key markets are already underway.
"Our mission is to build the first national cannabis house of brands," says Smith, "We aim to accomplish this goal by earning our customers' loyalty and trust, and want BellRock to be known for delivering the highest quality, most consistent and broadest portfolio of cannabis infused products in the industry."
BellRock remains committed to growing shareholder value. The company's buy-and-build growth strategy employs a three-pronged approach of enhancing its platform through strategic acquisitions, prioritizing profitable organic revenue growth, and continuously optimizing its costs and capital structure. On a pro forma basis, assuming BR Brands and Dixie had combined as of January 1, 2020, BellRock expects to generate in excess of $40 million in revenue in 2020, with clear plans to deliver exponential revenue and cash flow growth in 2021 and beyond.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced today that it has expanded its award-winning line of Select Oil brand products to its 15th state, Illinois - the nation's second-largest adult-use market after California - starting with its Select Elite Live cannabis oil cartridges.
Select, America's #1 Cannabis Oil Brand, is a lifestyle brand that was acquired by Curaleaf in February 2020. Select creates a variety of high-quality products that can be found in over a thousand dispensaries across 15 states, including Arizona, California, Colorado, Connecticut, Florida, Illinois, Maryland, Michigan, Nevada, New York, Ohio, Oklahoma, Oregon, Massachusetts, and Maine. As an industry leader, Select takes pride in having some of the most stringent and progressive testing practices in the industry and is committed to continuous innovation to ensure our customers get the best cannabis experience possible.
Select Elite Live combines high-quality, high-potency THC oil with live resin extract derived from fresh, frozen flower. Created with a proprietary formula, Elite Live is designed to capture the essence of the living plant with a higher terpene content when compared to a traditional distillate cartridge. The enhanced formula has quickly become a best-seller in every market where it has launched; in Florida alone, sales surpassed $1 million in less than one month. The oil is delivered by Select's unique cartridge technology, which helps to evenly distribute heat and deliver enhanced purity, flavor, and quality.
"The Select brand has worked diligently to earn its place as an industry leader and is rapidly becoming the first nationally-recognized cannabis brand," said Joe Bayern, President at Curaleaf. "Illinois is one of the largest adult-use cannabis markets in the country and one that has worked incredibly hard to address the need for reparation and normalization of our industry. We look forward to becoming part of the Illinois community, and serving the patients and consumers with the best in class cannabis consumer products available anywhere."
In July 2020, Curaleaf closed on its acquisition of Grassroots, giving the company the opportunity to continue developing innovative products and serving communities across the United States, including Grassroots' native state of Illinois. Select is slated to expand into Pennsylvania early next month. Both Illinois and Pennsylvania are among the largest and fastest-growing cannabis markets in the United States.
The Illinois Department of Revenue (IDOR) recently reported that, following the legalization of adult-use cannabis in the state on January 1, marijuana sales have been record-breaking month-over-month, contributing to the $100 million milestone of cannabis tax revenue collected.
Select products will be available at many of Illinois' leading dispensaries, including Greenhouse's retail locations in Deerfield, Litchfield, Morris, Mokena and Skokie which will fall under the Curaleaf umbrella and branding pending final regulatory approval. To find a dispensary near you that carries Select products, go to www.selectbetter.com and click "Find Us" for an interactive map of locations.
Shoppers Drug Mart Inc. announced the opening of its MediSystem® location in Edmonton. Owned and operated by Shoppers Drug Mart, MediSystem Inc. is an established specialty pharmacy that provides pharmaceutical dispensing and clinical pharmacy consulting services to the senior housing community and group home facilities.
Located at 12215-156 St NW in Edmonton, the new MediSystem Pharmacy is committed to optimizing the health, wellness and safety of all facility residents through the introduction of innovative technologies, continuing education, enhanced clinical services and seamless medication delivery.
"Since our inception in 1988 we've been bringing leading edge technology and personal care to long term care residents across Canada," says Sandra Daniel, Vice President of Operations and Clinical at MediSystem Pharmacy. "The opening of our new location in Edmonton will allow us to continue to support the health and well-being of the growing number of seniors in long term care and retirement home facilities through the most advanced, dependable, and personalized pharmacy care. Our investment today also reflects confidence in the future direction of health care in Alberta."
The Edmonton MediSystem staff will include a dedicated pharmacy team, including operational and consultant pharmacists to provide on-site, end-to-end support including one-on-one counseling. Providing access to medication 24 hours a day, 7 days a week, 365 days a year, the team will be highly accessible, ensuring that all clinical needs and emergency services are fully covered. These pharmacists, specializing in senior care, will also provide ongoing training and education that is tailored to optimize resident health outcomes and improve quality of life. Through a series of programs and events, including 1:1 training and hands on learning, MediSystem training focuses on continuous quality improvement processes, disease and drug management, health and wellness as well as other health-related topics.
MediSystem Pharmacy has a legacy of being first to market with innovative, technical solutions. Whether it be multi-dose strip packaging, comprehensive digital pen system, ClientCare portal, e-Health solutions or state-of-the-art dispensing machines, MediSystem Pharmacy's technology ensures management of all medication information in a real time environment, resulting in exceptional accuracy.
Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway® has officially entered the U.S. cannabinol (CBN) market with the release of two new CBN isolate products.
Not to be confused with cannabidiol (CBD), which has gained significant popularity over the past few years, CBN is another non-psychoactive cannabinoid found in the cannabis plant. Like the Company’s full-spectrum CBD products, Kannaway®’s CBN products are derived from all-natural hemp.
“We’re very excited to become one of the first major hemp-derived product producers to offer CBN,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is being researched in several different studies, including a 300 person study just announced on Oct. 28, for its potential sedation and sleep effects.”
This new product line includes:
● Kannaway® Pure CBN Liquid: Isolated CBN is combined with sustainably sourced medium-chain triglyceride (MCT) oil, providing an abundant source of essential fatty acids that help to enhance bioavailability naturally. Offered in a 1-ounce bottle with a convenient dropper, each product delivers roughly 30 servings of 10 mg of CBN each.
● Kannaway® Pure CBN Gel Capsules: Isolated CBN and MCT oil are also combined, but are presented in a convenient gel capsule form. They come in a 30-pack, with each gel capsule containing 20 mg of pure CBN.
“Though it may be too soon to predict the growth potential for the CBN market, analysts at the Nutrition Business Journal predict that the sleep supplement market will grow 30.1% this year,” said Kannaway CEO Blake Schroeder. “We intend to continue to stay up-to-date with the most recent discoveries in cannabinoid research and offer our customers the latest, most popular ingredients available in sleep science and other categories.”
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on Investorideas.com
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
